SIRT2 and hepatocellular carcinoma: In another study, Huang et al. also found that downregulation of SIRT2 reduced migration and invasion in human HCC cells, but revealed that SIRT2 inhibition increased PEPCK1 acetylation and suppressed its downstream E-cadherin pathway (52).